- NOK1.41bn
- NOK1.10bn
- NOK243.98m
Brief: Carasent First Day Of Trading On Nasdaq Stockholm Dec 9
Brief: Carasent Q3 Adjusted EBITDA NOK 12.4 Million
Brief: Carasent Expects Relisting To Nasdaq Stockholm To Be Completed In Dec 2024
Brief: Carasent Resolves On Cross-Border Merger Plan
Brief: Carasent Says EG Will Not Make Contemplated Take-over Offer
Brief: Carasent To Supply Ad Curis To Frelsesarmeen
Brief: Carasent Comments On EG's Intention To Launch Voluntary Cash Offer
Brief: EG Contemplates Voluntary Cash Offer To Acquire Carasent
Brief: Carasent Announces Revised Financial Targets
Brief: Carasent CEO Buys 135,000 Shares At NOK 10.18 Per Share
Brief: Carasent To Sell Confrere To Compodium International
Brief: Carasent Receives Request To Call EGM To Decide On Extraordinary Dividend
Brief: Carasent Group Signs Contract To Supply Metodika EPM To Volvat
Brief: Carasent Announces Long-Term Financial Targets
Brief: Carasent To Acquire Shares In Buy-Back Offering At About NOK 16 Per Share
Brief: Carasent Says Decided To Reduce Company's Significant Net Cash Position By Returning Nok 250 Million To Shareholders
Brief: Carasent Q1 Adjusted EBITDA Falls To NOK 4.9 Million
Brief: Carasent To Initiate Savings Program
Brief: Carasent Q4 Adj EBITDA Down At NOK 8.4 Million